The incident occurred near the Ras Tanura facility in the east of the country, a key export hub for oil transported through the Strait of Hormuz. By Vivian Nereim Reporting from Riyadh, Saudi Arabia ...

in the Persian Gulf as the supplier seeks to quickly increase production following early progress in US-Iran peace talks. At least eight empty vessels have congregated off the Ras Laffan facility ...

SINGAPORE, June 26 (Reuters) - Saudi Aramco resumed crude loadings on Friday at its Ras Tanura terminal in the Gulf after a near four-month halt, shipping data showed, as the world's biggest oil ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Qatar said it doesn’t expect liquefied natural gas exports to be impacted by an explosion at the Ras Laffan industrial complex which left 13 dead and 66 injured. Production has been halted at the ...

DUBAI, United Arab Emirates (AP) — An explosion tore through Qatar’s key natural gas export terminal Sunday night as workers tried to resume operations there after Iran bombed it during the war, ...

DOHA — An explosion tore through Qatar’s key natural gas export terminal Sunday night, injuring at least 54 people as another 18 were still missing hours later, authorities said. An incident during ...

An explosion tore through Qatar’s key natural gas export terminal Sunday night (June 21, 2026) as workers tried to resume operations there after Iran bombed it during the war, causing a fire that hurt ...

Authorities confirm deaths, say 66 injured Authorities say a 'technical accident' caused explosion Blast occurred during restart at Barzan gas supply facility DOHA, June 22 (Reuters) - Thirteen people ...

b RAS G12, G13 or Q61 mut or no RAS mut identified. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting II. This abstract does not include a full text component.

This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.

Current therapies offer limited benefit for patients with previously treated metastatic pancreatic ductal adenocarcinoma (mPDAC). Aberrant activation of the RAS pathway is the key driver of PDAC, with ...